Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023868 · ClinicalTrials.gov registry record · Phase 3
Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)
A Phase 3 study, sponsored by American College of Radiology Imaging Network.
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00023868: Clinical Trial Phase 3 study, sponsored by American College of Radiology Imaging Network.
NCT00023868 is a Phase 3 study that was terminated before completion, run by American College of Radiology Imaging Network. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00023868, a Phase 3 study, was terminated before completion, sponsored by American College of Radiology Imaging Network.
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keeping chemotherapy drugs near the tumor. It is not yet known if chemoembolization is more effective than standard chemotherapy in treating metastatic cancer. PURPOSE: This phase I trial and randomized phase III trial is studying the effectiveness of chemoembolization in treating patients who have colorectal cancer metastatic to the liver.
Interventions
- DRUG cisplatin
- DRUG fluorouracil
- DRUG doxorubicin hydrochloride
- DRUG irinotecan hydrochloride
- DRUG FOLFIRI regimen
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-11-01 |
| Est. Completion | 2002-09-25 |
| Phase | Phase 3 |
Why NCT00023868 stopped before completion
NCT00023868 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00023868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00023868 about?
NCT00023868 is a clinical study titled "Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)". RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keep...
What is the current status of trial NCT00023868?
This trial is currently terminated. It is a Phase 3 study. The study started on 2001-11-01. Estimated completion is 2002-09-25.
What interventions are being tested in trial NCT00023868?
The interventions under investigation include: cisplatin (DRUG), fluorouracil (DRUG), doxorubicin hydrochloride (DRUG), irinotecan hydrochloride (DRUG), FOLFIRI regimen (DRUG).
Who is sponsoring clinical trial NCT00023868?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI